A carregar...
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immuno-oncology therapies are improving cancer treatments beyond the former standard of care, as evidenced by the recent and continuing clinical approvals for immunotherapies in a broad range of indications. However, a majority of patients (particularly those with immunologically cold tumors) st...
Na minha lista:
| Publicado no: | BioDrugs |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790338/ https://ncbi.nlm.nih.gov/pubmed/31321623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00367-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|